InvestSMART

Wellnex Life Limited (ASX: WNX) - Share Price

- Current share price for WNX : $0.066

Wellnex Life Limited (WNX) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is involved in the development, marketing and selling of premium brands and products for the growing health and pharmaceutical market and licensing of our unique and innovative product to domestic and global pharmaceutical companies.

WNX General Information +

ASX Code WNX
Website http://wellnexlife.com.au
Industry/Sector Packaged Foods & Meats
Market Cap ($M) 4
WNX Share Price $0.066
Day High $0.000
Day Low $0.000
Last Close $0.066
WNX Share Price Movement - ( No change )
Prices as at 16:40, 2 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Wellnex Life Limited (WNX) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Wellnex Life Limited (WNX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Wellnex Life Limited (WNX) price-sensitive announcements

WNX - Appendix 4C and Quarterly Report for Sep 2026 Quarter
Wellnex Life Limited’s Quarterly Update and Appendix 4C for the September 2026 quarter rep
Wellnex Life Limited (WNX)
30 Oct 2026 | 9:09 AM
WNX - Wellnex Life Releases FY26 Annual Report
Wellnex Life Limited announced its audited FY26 annual report for the year ended 30 June 2
Wellnex Life Limited (WNX)
31 Aug 2026 | 6:01 PM
WNX - FY26 Appendix 4E and Annual Report
Wellnex Life Limited’s FY26 Appendix 4E and Annual Report for the year ended 30 June 2026
Wellnex Life Limited (WNX)
31 Aug 2026 | 6:00 PM
WNX - Sale of Pain Away for up to A$21.3 million
Wellnex Life Limited has entered into a binding agreement to sell its Pain Away business a
Wellnex Life Limited (WNX)
6 Aug 2026 | 4:35 PM

Wellnex Life Limited (WNX) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Wellnex Life Limited (WNX)
ORDINARY FULLY PAID
Consumer Staple $5 Appendix 4C and Quarterly Report for Sep 2026 Quarter 30 Oct 2026 9:09AM $0.066 $0.066 fallen by 0%
Wellnex Life Limited (WNX)
ORDINARY FULLY PAID
Consumer Staple $5 Notice of Annual General Meeting/Proxy Form 29 Oct 2026 4:41PM $0.066 $0.066 fallen by 0%
Wellnex Life Limited (WNX)
ORDINARY FULLY PAID
Consumer Staple $5 Ceasing to be a substantial holder 5 Oct 2026 4:36PM $0.082 $0.066 fallen by 19.51%
Wellnex Life Limited (WNX)
ORDINARY FULLY PAID
Consumer Staple $5 Change of Director's Interest Notice 5 Oct 2026 4:34PM $0.082 $0.066 fallen by 19.51%
Wellnex Life Limited (WNX)
ORDINARY FULLY PAID
Consumer Staple $5 Completion and Settlement of Sale of Pain Away 11 Sep 2026 4:13PM $0.081 $0.066 fallen by 18.52%
Wellnex Life Limited (WNX)
ORDINARY FULLY PAID
Consumer Staple $5 Results of Meeting 8 Sep 2026 10:42AM $0.081 $0.066 fallen by 18.52%

WNX Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$3.72 -$11.80 -70.90% 0.00 0.00 0.00% 0.0%
2025A -$11.80 -$40.30 -12.80% 0.00 0.00 0.00% 0.0%
2024A -$8.68 -$46.20 -49.60% 0.00 0.00 0.00% 0.0%

WNX Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
The a2 Milk Company Limited (A2M) $5,038M -0.5230 0.9636 0.2969 56.0324 28.5361 22.0032 2.27% 2.45% 3.15%
Bega Cheese Limited (BGA) $1,924M -3.8555 0.1867 0.2091 27.4313 23.1165 19.1185 2.31% 2.70% 3.34%
Cobram Estate Olives Limited (CBO) $1,326M -0.7456 0.0000 0.0000 95.8478 0.0000 0.0000 1.62% 0.00% 0.00%
Ricegrowers Limited (SGLLV) $997M -0.0114 -0.2480 0.1948 14.0625 18.7013 15.6522 4.86% 4.86% 4.86%
Wellnex Life Limited (WNX) $5M -0.7087 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

WNX Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 0.65 0.00
Market 0.30 13.20 1.02 0.75
Sector 0.40 14.60 0.86 0.90

WNX Directors

Name Position Start Date
Mr Eric Jiang Executive Director, Interim Chairman 13 Sep 2016
Mr Jeffrey Yeh Non-Executive Director 15 Jan 2024
Mr Ash Vesali Non-Executive Director 18 Sep 2025
Mr Hilton Keith Wood Non-Executive Director 12 Jun 2026

Wellnex Life Limited (WNX) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
30 Sep 2026 YEH, Jeffrey Sell Indirect Shares 4,322,886 $0.080 $345,830.880
5 Mar 2025 BOZINOVSKI, Zlatko (Zack) Issued Indirect Shares 184,615 $0.650 $120,000.000
5 Mar 2025 YEH, Jeffrey Issued Indirect Shares 1,999,999 $0.650 $1,300,000.000

See all changes in directors' interest & trades for Wellnex Life Limited (WNX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

WNX Management

Name Position
Zheng (Kobe) Li Company Secretary

WNX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Wellnex Life Limited (WNX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
2,629,181 (3.60%) JYSF Management Pty Ltd

WNX Calendar of Events

Date Event
30 August 2027 Report (Annual)
30 August 2027 Report (Prelim)
26 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.